“Effects of Galcanezumab on Acute Medication Use and Health Care Resource Utilization in Treatment-Resistant Migraine: Results from Randomized, Double Blind, Placebo-Controlled Clinical Trial, Conquer”. 2020. Headache Medicine 11 (Supplement): 27. https://doi.org/10.48208/HeadacheMed.2020.Supplement.27.